| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 01/03/2002 | WO2002000607A1 Amide compounds and use thereof |
| 01/03/2002 | WO2002000606A1 Biphenyl compound |
| 01/03/2002 | WO2002000602A1 Benzophenones and sulfones as inhibitors of glycine uptake |
| 01/03/2002 | WO2002000586A1 The novel propanedione derivatives and their use as polymerizable uv-absorbent |
| 01/03/2002 | WO2002000339A2 Ligands and catalyst systems thereof for ethylene oligomerisation to linear alpha olefins |
| 01/03/2002 | WO2002000200A1 Novel process for preparing crystalline particles |
| 01/03/2002 | WO2001070693A3 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors |
| 01/03/2002 | WO2001062233A3 Adenosine receptor modulators |
| 01/03/2002 | WO2001054501A3 Herbicidal composition |
| 01/03/2002 | WO2000055358A9 4-(4-hydroxystyryl)pyridine-containing substrates for an analyte dependent enzyme activation system |
| 01/03/2002 | US20020002285 Process for preparing substituted pyridines |
| 01/03/2002 | US20020002199 Suitable for treating type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance or obesity |
| 01/03/2002 | US20020002191 Fluoroalkoxy-substituted benzamide dichloropyridinyl N-oxide PDE4 inhibitor |
| 01/03/2002 | US20020002190 Antidiabetic agents increasing the expression of glucokinase (GK) to improve glucose tolerance; increase in glucose exposure coupled through GK in beta-cells to increase insulin secretion and in hepatocytes to increase glycogen deposition |
| 01/03/2002 | US20020002183 Benzamides and related inhibitors of factor Xa |
| 01/03/2002 | US20020002158 Potentiation of glutamate receptor function; treating central nervous system disorders |
| 01/03/2002 | US20020002152 Methionine aminopeptidase type 2 inhibitors; n'-((2S,3R)-3-amino-2-hydroxy-5-(isopropylsulfanyl)pentanoyl)-3-chloro benzoyl hydrazide |
| 01/03/2002 | US20020002150 Cyclopentane(ENE)heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
| 01/03/2002 | US20020001732 Polymer electroluminescent device |
| 01/03/2002 | DE10029371A1 Heterocyclische Aminoalkylpyridinderivate als Psychopharmaka Heterocyclic Aminoalkylpyridinderivate as psychotropic drugs |
| 01/03/2002 | CA2413469A1 Ligands and catalyst systems thereof for ethylene oligomerisation to linear alpha olefins |
| 01/03/2002 | CA2411552A1 Glucagon antagonists/inverse agonists |
| 01/02/2002 | EP1167352A1 A method for producing pyridine bases |
| 01/02/2002 | EP1167342A1 Novel substituted nitrocatechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
| 01/02/2002 | EP1165738A1 Composition and method for bleaching a substrate |
| 01/02/2002 | EP1165576A1 Process for preparing amine platinum complexes |
| 01/02/2002 | EP1165552A1 C7 carbonate substituted taxanes as antitumor agents |
| 01/02/2002 | EP1165551A1 C10 carbamoyloxy substituted taxanes as antitumor agents |
| 01/02/2002 | EP1165550A1 C10 carbonate substituted taxanes as antitumor agents |
| 01/02/2002 | EP1165547A1 Substituted benzoylpyrazoles as herbicides |
| 01/02/2002 | EP1165543A1 PROCESS FOR PREPARING S-(R*,S*)] -$g(b) - 1- 1-OXO-3- (4-PIPERIDINYL) PROPYL] -3-PIPERIDINYL] CARBONYL] AMINO] -3- PYRIDINEPROPANOIC ACID AND DERIVATIVES |
| 01/02/2002 | EP1165534A2 Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in the production of medicaments |
| 01/02/2002 | EP1165530A2 Dihetero-substituted metalloprotease inhibitors |
| 01/02/2002 | EP1165516A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 01/02/2002 | EP1165515A1 Pyridine-2,3-dicarboxylic acid diamides |
| 01/02/2002 | EP1165505A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 01/02/2002 | EP1165504A2 INHIBITORS OF LFA-1 BINDING TO ICAMs AND USES THEREOF |
| 01/02/2002 | EP1165502A1 Diaryl derivatives and their use as medicaments |
| 01/02/2002 | EP1165501A1 Alkenyl- and alkynyl-containing metalloprotease inhibitors |
| 01/02/2002 | EP1165500A1 Amide derivatives as inhibitors of matrix metalloproteinases,tnf-alpha,and aggrecanase |
| 01/02/2002 | EP1165496A1 Substituted aniline compounds |
| 01/02/2002 | EP1165494A2 Hsv primase inhibitors |
| 01/02/2002 | EP1165485A2 Processes for preparing pesticidal intermediates |
| 01/02/2002 | EP1165072A2 Valdecoxib compositions |
| 01/02/2002 | EP1165064A2 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 01/02/2002 | EP1107948A4 An improved synthesis of 3-hydroxy-4-amino-benzonitrile |
| 01/02/2002 | CN1329597A Pyridinium derivatives for treatment of diabetic and aging-related vascular complications |
| 01/02/2002 | CN1329596A Picolinamide derivatives and pest controllers containing same as active ingredient |
| 01/02/2002 | CN1329589A N-aralkylaminotetralins as ligands for neuroptide YY5 receptor |
| 01/02/2002 | CN1329281A Colour photosensitive imaging element containing closed developer |
| 01/02/2002 | CN1328824A Compound for curing female sexual disorder |
| 01/02/2002 | CN1077101C 2-chloro-3,5-bis (trifluoromethyl)phenyl benzoyl urea derivative and process for preparing same |
| 01/01/2002 | US6335460 Treating retroviral infections, including human immunodeficiency virus, and aids |
| 01/01/2002 | US6335459 Prostaglandin i2 receptor modulators; treating tissue necrosis, premature uterine contraction, gastric ulceration, sexual dysfunction, menstrual pain and improper wound healing, immunoregulation, platelet aggregation or neutrophil function |
| 01/01/2002 | US6335446 Quinolinium- and pyridinium-based fluorescent dye compounds |
| 01/01/2002 | US6335367 Fungicidal and insecticidal benzyloxy cyclopropyl substituted aromatic compounds |
| 01/01/2002 | US6335354 Aminopyridines and methods of using thereof |
| 01/01/2002 | US6335353 3-hydroxypyridin-4-one derivative; iron deficiency anemia and thalassemia treatment |
| 01/01/2002 | US6335345 Spiro compounds |
| 01/01/2002 | US6335334 Hypertensive agents, anticoagulants; cardiovascular and sexual disorders, angina pectoris, and atherosclerosis |
| 01/01/2002 | US6335325 Crop protection |
| 01/01/2002 | CA2056799C 1,4-dihydropyridine derivatives and methods of producing the same |
| 12/27/2001 | WO2001098303A1 Novel process for the preparation of pyrazolopyrimidinones |
| 12/27/2001 | WO2001098293A1 Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals |
| 12/27/2001 | WO2001098291A2 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 12/27/2001 | WO2001098284A1 Process for the preparation of pyrazolopyrimidinones |
| 12/27/2001 | WO2001098274A2 Sulphonamide derivatives |
| 12/27/2001 | WO2001098262A1 Amidine derivatives as selective antagonists of nmda receptors |
| 12/27/2001 | WO2001098256A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 12/27/2001 | WO2001098251A1 Novel substituted nitrocatechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
| 12/27/2001 | WO2001098248A2 Hiv integrase inhibitors |
| 12/27/2001 | WO2001097810A2 Use of therapeutic benzamide derivatives |
| 12/27/2001 | WO2001097751A2 New formulation comprising a betablocker and optionally a cholesterol-lowering agent |
| 12/27/2001 | WO2001085719A9 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 12/27/2001 | WO2001060349B1 Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof. |
| 12/27/2001 | US20010056203 O-aminophenolcarboxylic acid and o-aminothiophenolcarboxylic acid |
| 12/27/2001 | US20010056107 Cyano and carboxy derivatives of substituted styrenes are inhibitors of tumor necrosis factor alpha , nuclear factor kappa B, and phosphodiesterase and can be used to treat cachexia, endotoxic shock, inflammatory conditions etc. |
| 12/27/2001 | US20010056105 Useful as cosmetic for hair and body hygiene, and for treatment of dermatological complaints, with an inflammatory and/or immunoallergic component of rheumatic or respiratory type, cardivascular and opthalmogical disorders |
| 12/27/2001 | US20010056099 Method of reducing morbidity and the risk of mortality |
| 12/27/2001 | US20010056088 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors |
| 12/27/2001 | US20010056081 Treatment of cerebrovascular disease |
| 12/27/2001 | US20010054559 Selective electrochemical reduction of halogenated 4-aminopicolinic acids |
| 12/27/2001 | CA2413878A1 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 12/27/2001 | CA2412985A1 Hiv integrase inhibitors |
| 12/27/2001 | CA2411100A1 New formulation comprising a betablocker and optionally a cholesterol-lowering agent |
| 12/26/2001 | CN1328548A Benzamide derivatives as thrombin inhibitors |
| 12/26/2001 | CN1328547A 2,3-Disubstituted pyridine derivatives, process for preparation thereof, drug compositions containing the same and intermediates for preparation |
| 12/26/2001 | CN1328545A Hydrazine derivatives |
| 12/25/2001 | US6333425 Ionic compounds derived from malononitrile in which anionic charge is delocalized; excellent properties of solubility and dissociation |
| 12/25/2001 | US6333358 Aryloxyaniline derivatives |
| 12/25/2001 | US6333341 Tumor necrosis factor, antiinflammatory agents and analgesics |
| 12/25/2001 | US6333337 Potassium channel inhibitors |
| 12/25/2001 | US6333082 Liquid crystalline (E,E)-butadiene compounds and mixtures and devices containing such compounds |
| 12/21/2001 | CA2351129A1 Novel substituted nitrocatechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
| 12/20/2001 | WO2001096334A2 Heteroarylalkanoic acids as integrin receptor antagonists |
| 12/20/2001 | WO2001096327A1 BIOISOSTERIC BENZAMIDE DERIVATIVES AND THEIR USE AS APoB-100 SECRETION INHIBITORS |
| 12/20/2001 | WO2001096323A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096310A1 Dihydrostilbene alkanoic acid derivatives useful as vitronectin antagonists |
| 12/20/2001 | WO2001096309A1 Hydroxyformamidine derivatives and medicines containing the same |
| 12/20/2001 | WO2001096308A1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |